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Abstract
Background: Complementary and alternative medicine (CAM) is widely used in Germany, with some treatments
eligible for health insurance reimbursements. CAM encourages patients to play an active role in their healing
process. The belief that a person’s own behavior influences health is assessed as the internal health locus of control
(IHLOC). Studies on the association between IHLOC and CAM use yield inconsistent results. Using various indicators
of CAM use, we evaluated whether there were differences in IHLOC between different groups of CAM users.
Methods: A cross-sectional online survey was conducted. IHLOC was compared between participants with high
and low appraisal of CAM, between participants who used different types of medications (none, CAM, conventional,
both), and who consulted with different health care professionals (none, CAM, conventional, both). Independent
samples t-tests and ANOVAs were conducted for the total group and for subgroups of chronically ill and healthy
participants. Post-hoc, we conducted a multivariate linear regression evaluating which indicators of CAM use or
other characteristics showed the strongest association with IHLOC.
Results: A total of 1,054 undergraduate students completed the survey. Participants with high CAM appraisal
showed higher IHLOC than those with low CAM appraisal, regardless of whether they were chronically ill (p < .001).
Participants without chronic conditions showed higher IHLOC when only using CAM medications than when using
either conventional medications alone or both conventional and CAM medications (p < .05). All participants showed
higher IHLOC when visiting only CAM practitioners than when visiting either only conventional or both
conventional and CAM practitioners (p < .05). CAM appraisal was associated the strongest with IHLOC in the linear
regression model.
Conclusions: Generally, participants using CAM more or exclusively, and participants with higher appraisal of CAM
showed higher IHLOC than those with less CAM use or lower CAM appraisal. Because of the cross-sectional design,
it is not possible to determine whether differences in IHLOC are reasons for or consequences of CAM use. Research
using a longitudinal design is needed. The sample, though more representative than most student samples, might
not represent the general population. Studies evaluating clinical populations might add to the findings.
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Background
Therapies belonging to the spectrum of complementary
and alternative medicine (CAM) are widely used in
Germany [1,2] and worldwide [3,4]. According to a
recent systematic review, [5] herbal medicine and
chiropractic care are the most popular CAM treat-
ments in Germany, however, the data differs depending
on the definition of CAM and the CAM professionals
included (physicians only or also lay practitioners).
While in Germany, some CAM treatments, such as
acupuncture for chronic low back pain and osteoarth-
ritis of the knee, are generally reimbursed, it is differ-
ent in other countries where reimbursement depends
on the patient’s insurance. The association between the
use of CAM and its users’ characteristics and beliefs
has been investigated in numerous studies (e.g., [6-8]).
One of the characteristics that has been examined
repeatedly is internal health locus of control (IHLOC).
IHLOC describes the perception that one can influence
one’s health (as opposed to health being determined by
powerful others, e.g., physicians, or by chance, fate, or
God [9,10]). Barrett et al. interviewed CAM practi-
tioners about their views on health and health care,
coming to the conclusion that the patients’ responsibil-
ity for their own health is an important part of CAM
[11]. The patient works together with the health care
professional to improve his or her health. Often this
involves changing aspects of one’s lifestyle (e.g., diet or
sleeping behavior), or practicing certain techniques (e.g.,
breathing or meditating). Taking responsibility for
their recovery in this way might be one of the reasons
patients choose CAM in the first place.
In a systematic review of beliefs of CAM patients, the
majority of studies found correlations between the use
of CAM and the desire for personal responsibility and
health empowerment in general [7]. Qualitative studies
come to that conclusion as well [12,13]. However, when
looking at IHLOC in the same review, only three studies
[14-16] showed positive correlations between internal locus
of control and CAM use, and ten showed no relationship
[7]. However, this result must be regarded with caution as
most of the studies included in the review used a meas-
ure for IHLOC [17] that has questionable reliability
[18]. Additionally, the assessment of CAM use varies
from study to study, including giving the participants a
list of CAM modalities and defining everybody as a
CAM user who has used at least one of these modalities,
and recruiting participants at CAM-based treatment
centers and comparing them to participants recruited at
GP-based treatment centers. More recent studies, not
included in the above review, also come to ambiguous
results regarding associations between CAM use and
IHLOC. No relationship between internal locus of con-
trol and requests for CAM was found in an inpatient
sample in Germany [19]. However, positive relationships
have been found in cancer patients [20,21], in patients
with lower back pain [22], in the healthy population
[23], and in a mixed sample [24]. The picture, therefore,
remains unclear and warrants further investigation.
The aim of this study was to evaluate differences in
IHLOC between participants with high and low ap-
praisal of CAM, with different patterns of medication
use (none, only CAM, only conventional, or both), and
with different patterns of health-care consultations
(none, only CAM practitioners, only conventional practi-
tioners, or both) using a large sample.
Methods
Subjects and Setting
The study was designed as an online survey conducted
at a university (FernUniversität in Hagen) that was also
used for the validation of a scale to measure body-efficacy
expectation (BEE) described in a different publication
[25]. In this manuscript, we report the methods relevant
to this publication; for overall methods, see Schützler
and Witt, 2013 [25].
As an anonymous survey, the study did not require
the approval of an ethics committee.
Measurement Instruments
Internal Health Locus of Control (IHLOC)
IHLOC [9,10,26] was assessed with the seven items of
the “internal” subscale of the German version of the
multidimensional health locus of control questionnaire
[27]. Items assess the extent to which people believe that
they are responsible for their health, e.g., “If I take the
right actions, I can stay healthy”. The items are rated on
a 6-point Likert scale ranging from 1 (strongly agree) to
6 (strongly disagree). To calculate the total score, the
scores are reversed so that higher total scores represent
higher IHLOC values. Because the manual for the ques-
tionnaire does not contain instructions for dealing with
missing values, an IHLOC score was only computed for
participants who had no missing values. Cronbach’s alpha
of the scale in our sample was .84.
Chronic conditions
Participants were asked if they had a chronic condition
and, if so, what chronic condition they had. They were
also given a list with acute conditions and were asked to
check any condition they suffered from in the last six
months as well as the duration of the condition. If the
duration was >100 days, the condition was considered to
be chronic and was reclassified as such [25].
Appraisal of CAM
Participants were presented with a list of CAM treat-
ments (including the option to specify three more CAM
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treatments not on the list) and were asked to answer
one of the following: “I have positive experience with
this treatment”, “I have negative experience with this treat-
ment,” “I can imagine this treatment is effective, but have
not tried it yet”, “I do not think this treatment is effective”,
or “I do not know about this treatment/no opinion”.
The number of treatments that participants reported
having had positive experiences with or regarded as ef-
fective even though they had not tried them personally
was used as a surrogate measure for positive CAM ap-
praisal (appraisal score, see also [25]).
Medication profile
Participants were given a list of prescription and over-
the-counter drugs and reported if they had used them in
the six months prior to the study. These included: allo-
pathic drugs (e.g. but not limited to pain killers, antibi-
otics, detumescing nasal sprays, beta-blockers, drugs for
thyroid dysfunction, ointments) and psychiatric drugs,
together regarded as conventional medications, phyto-
medicine, homeopathic drugs, TCM herbs, Bach flowers,
and essential oils, regarded as CAM medications. Par-
ticipants could also list other medications that were then
screened and classified as either conventional or CAM
medications. We assigned the participants to one of the
following groups: (1) uses only CAM medications, (2) uses
only conventional medications, (3) uses both CAM and
conventional medications, and (4) uses no medications
at all [25].
Consultation profile
Participants were given a list of physicians and health
practitioners and reported if they had visited them in the
six months before the study: general practitioners
or specialists (e.g. but not limited to internists, ortho-
pedic specialists, gynecologists, otorhinolaryngologists,
eye specialists, etc.), together regarded as conventional
consultants, naturopathic MDs, homeopathic MDs,
Traditional Chinese Medicine (TCM) MDs, anthropo-
sophic medicine MDs and non-medical practitioners
(German “Heilpraktiker”), together regarded as CAM
consultants. They could also list other practitioners that
were screened and classified as either conventional or
CAM consultants. We then assigned the participants to
one of the following groups: (1) only sees CAM consu-
ltants, (2) only sees conventional consultants, (3) sees
both CAM and conventional consultants, and (4) does
not consult with any health care professionals [25].
Statistical methods and analyses
The sample was split into two subgroups based on the
CAM appraisal score resulting in one subgroup with
low appraisal and one with high appraisal of CAM. An
independent samples t-test was conducted to compare
IHLOC in both subgroups.
One-factor ANOVAs were used to compare IHLOC of
the participants according to their medication and con-
sultation profiles (for more details see [25]). Orthogonal
linear contrasts were used to compare pre-defined
groups: we compared IHLOC of participants without
any medication use with all other participants, and par-
ticipants who only used CAM medications with those
who only used conventional, or both CAM and conven-
tional, medications. Accordingly, we compared IHLOC
of participants reporting no consultations with any
health care professionals with all others, and partici-
pants who only visited CAM practitioners with those
who only visited conventional, or both CAM and con-
ventional, practitioners.
To check if participants with and without chronic con-
ditions differed in their IHLOC, an independent samples
t-test was conducted to compare the two groups. If sig-
nificant, all analyses were conducted for the subgroups
with and without chronic conditions in addition to the
analysis of the total sample.
In addition to these analyses, a multivariate linear re-
gression model was built to evaluate which variables
contributed the most to high or low IHLOC when con-
sidering them all together. The IHLOC score was the
outcome and the following variables were added to the
model as predictors: sex, age, presence of a chronic con-
dition, appraisal score (as a numerical variable), and
medication and consultation profiles. Factors of the lat-
ter were dummy-coded, and taking only conventional
medication or visiting only conventional practitioners
served as the reference category. No selection of predic-
tors was conducted, rather, all predictors were left in the
model, regardless of whether they were significant or
not. The variance inflation factor was computed for all
variables to check for multicollinearity.
All computations were performed using the IBM Stat-
istical Package for the Social Sciences (SPSS), Version 20
for Windows. Because statistically significant differences
in a large sample are not necessarily relevant, we com-
puted effect sizes for the t-tests and ANOVAs using the
program G*Power 3.1 [28].
Results
A total of 1,054 students (mean age 32.74 years, SD =
9.32) completed the survey; 80.4% of the sample were
women, 17.9% were men, and 1.7% did not indicate their
gender; 34.8% of the participants reported a chronic
health condition; and 77.3% of the participants had tried
at least one CAM treatment. With the majority of CAM
treatments, the participants had positive experiences, or
at least assumed them to be effective (Figure 1). IHLOC
scores were missing for 3.2% of the sample. Because this
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number is relatively small we decided to not impute
missing values.
We used Q-Q plots to check the normality assump-
tions for the t-tests and ANOVAs. Only slight deviations
from normality were found so we decided to conduct
parametric tests. T-tests and ANOVAs are relatively ro-
bust against violations of normality assumptions as long
as the sample size is large enough. Additionally, most
studies evaluating IHLOC use comparisons of means
which makes comparisons between studies difficult
when conducting different analyses.
Participants without chronic conditions had higher
IHLOC (M = 29.96, SD = 4.53) than participants suffe-
ring from a chronic condition (M = 28.32, SD = 5.46;
p < .001, effect size d = .33). Therefore, all of the following
analyses were computed for the total sample, and separate
analyses were performed for participants with and without
chronic conditions. Appraisal scores were between 0 and
11 with a mean of 5.32 (SD = 2.40) and a median of 6. The
sample was split into one group with low CAM appraisal
(scores of 0–5) and one with high CAM appraisal (scores
of 6–11). This corresponds to a split where one group has
scores below the mean and the other has scores above the
mean. A median split, which would have been the normal
procedure for planned group comparisons, was not feas-
ible because 159 participants had a score of 6, i.e., the me-
dian itself. The low appraisal group had a mean appraisal
score of 3.20 (SD = 1.64) and the high appraisal group had
a mean appraisal score of 7.21 (SD = 0.96). IHLOC dif-
fered significantly in these groups, with higher values ob-
served in participants with a high appraisal of CAM. This
was true both for the total sample (MHigh Appraisal = 30.10
(SD = 4.80), MLow Appraisal = 28.47 (SD = 4.92), p < .001,
d = .34) and for the subgroups with a chronic condition
(MHigh Appraisal = 29.27 (SD = 5.08), MLow Appraisal = 27.17
(SD = 5.70), p < .001, d = .39) and without a chronic con-
dition (MHigh Appraisal = 30.59 (SD = 4.60), MLow Appraisal =
29.24 (SD = 4.34), p < .001, d = .30). According to Cohen’s
conventions for standard mean differences, effect sizes
of .2, .5 and .8 correspond to small, medium and large
effects [29]. Therefore, the effects were small to mode-
rate as is reflected in how they correspond to small
numerical differences on the IHLOC scale.
Participants who only used CAM medications showed
the highest IHLOC results, followed by participants who
did not use any medications, those who used both CAM
and conventional medications, and lastly those who only
used conventional medications. This pattern was found
in the total sample as well as in the subgroups of partici-
pants with and without chronic conditions. ANOVAs
comparing the participants according to their medica-
tion use showed significant differences with a small ef-
fect size for the total sample, but not for the subgroups
of participants with and without chronic conditions
(Table 1). The linear contrasts showed that the overall
effect was due to significantly higher IHLOC scores in
participants who only used CAM medications compared
to those who only used conventional or both CAM and
conventional medications, while the difference between
those who did not use any medications at all and all
other participants was not significant (Table 2). This was
also true for participants without chronic conditions, but
not for those with a chronic condition (Table 2).
Participants who only consulted CAM practitioners
showed the highest IHLOC results, followed by those
who did not see any practitioners, those who consulted
both CAM and conventional practitioners, and lastly,
those who consulted only conventional practitioners.
This pattern was found in the total sample as well as in
the subgroups of participants with and without chronic
Figure 1 Experience with complementary and alternative medicine.
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conditions (Table 3). ANOVAs comparing the partici-
pants according to the health care professionals they vi-
sited yielded significant overall results in the total
sample as well as in the subgroups of participants with
and without chronic conditions (Table 3). The effects
were of moderate size. The subgroup analyses showed
that this overall result was due to a significantly higher
IHLOC in participants who only visited CAM practi-
tioners compared to those who visited both conventional
and CAM practitioners or conventional practitioners
only. This was found in the total sample and both sub-
groups (Table 4).
The variance inflation factors for all variables were ap-
proximately 1, and the highest value was 1.6, indicating
little multicollinearity. The linear regression model
showed that the appraisal score (beta = .15, p < .001), the
presence of a chronic condition (beta = −.11, p < .001),
not visiting any health-care professionals (beta = .17,
p < .001), and visiting only CAM practitioners (beta = .11,
p < .01) were significant predictors for IHLOC. Suffering
from a chronic condition was associated with a lower
IHLOC, while the three others were associated with a
higher IHLOC. All other predictors were not significant
(Table 5). Despite the highly significant predictors, the
explained variance in IHLOC was only 9%.
Discussion
We aimed to determine whether IHLOC differed accor-
ding to CAM appraisal and the use of different medica-
tions (only CAM, both conventional and CAM, only
conventional, or none) or chosen health care professionals
(only CAM, both conventional and CAM, only conven-
tional, or none). Because the study was observational, one
must keep in mind that the study population is often het-
erogeneous, with the CAM group including more patients
with chronic illnesses. It has been shown that poor health
status is a predictor for CAM use [6]. Additionally, a
chronic condition might lead to lower IHLOC results be-
cause it has been shown that IHLOC scores are higher in
healthier subjects [30]. Indeed, in our sample the partici-
pants suffering from chronic conditions showed lower
IHLOC than participants without chronic conditions.
Therefore, we controlled for possible confounding by con-
ducting subgroup analyses of participants with and with-
out chronic conditions.
The proportion of participants who had used at least
one CAM treatment was higher than previously reported
for the general German population [2,31]. However, our
study population was a student population whose social
statuses might be higher than that of the general po-
pulation. A higher social status has been found to be a
predictor of CAM use [1,31]. The proportion of parti-
cipants with a chronic condition was comparable to that
of the general German population [32].
Higher appraisal of CAM was moderately related to
higher IHLOC, regardless of whether participants had a
chronic condition. Focusing on the medication use of
the participants, differences were found between those
participants who only used CAM medications and all
others; however, not for the chronically ill participants.
This indicates that the presence of a chronic condition is
a more important predictor of IHLOC than the type of
Table 1 IHLOC according to medication use in the past six months
Total group Chronic condition No chronic condition
N Mean (SD) N Mean (SD) N Mean (SD)
CAM medication only 98 30.74 (4.92) 23 29.87 (5.43) 75 31.01 (4.76)
Conventional medication only 341 28.87 (5.03) 143 28.01 (5.55) 197 29.49 (4.54)
Both 313 28.95 (4.64) 151 28.11 (4.99) 160 29.80 (4.13)
No medication 268 29.89 (4.99) 40 29.30 (6.70) 219 30.13 (4.67)
Total 1020 29.34 (4.93) 357* 28.32 (5.46) 651* 29.96 (4.53)
F (df) 5.52 (3,1016) 1.27 (3,353) 2.25 (3,647)
p <.01 .284 .081
Effect size f .13 .11 .10
*Sizes of subgroups do not add up to 1020 because of missing data regarding the presence/absence of a chronic condition.
Table 2 Subgroup comparisons regarding medication
Total group Chronic condition No chronic condition
Difference
in IHLOC
t (df) p Difference
in IHLOC
t (df) p Difference
in IHLOC
t (df) p
No medication vs. any medication 1.10 1.00 (1016) .32 1.90 .66 (353) .51 .08 .07 (647) .94
CAM medication only vs. CAM and
conventional or conventional medications only
3.67 3.46 (1016) <.01 3.62 1.53 (353) .13 2.74 2.39 (647) <.05
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medication used. For the type of health care professional
the participants consulted, there were differences be-
tween the participants who only consulted CAM practi-
tioners and all others. This was even true for the group
with a chronic condition. The results seem to support
those studies that found IHLOC to be positively related
to CAM use [14-16,20-24].
When considering CAM appraisal, medication and
consultation profiles, chronic conditions as well as sex
and age in one model, we found that CAM appraisal
had the strongest association with IHLOC, followed by
suffering from a chronic condition (negative association),
not visiting any health care professionals or only visiting
CAM practitioners. However, all of the variables com-
bined only explained 9% of the variance in IHLOC. This
indicates that there are other factors associated with
IHLOC that were not included in our model. We only
assessed whether participants had a chronic condition;
however, how they manage it might be more important
regarding IHLOC. This points to self-efficacy expecta-
tions [33] as one important factor.
Strengths of our study include the large, heteroge-
neous sample. As described in the validation publication
of the BEE scale [25], this was not an ordinary student
sample: the FernUniversität in Hagen is the only dis-
tance learning university in Germany. Students vary con-
siderably in age, lifestyles, and previous knowledge and
experiences. The university has no grade point enroll-
ment cut-off, and many students have work experience
or work during their course of studies (in fact, 80% do
so, [34]), and many have children.
CAM use was assessed in several ways: We used an
appraisal score that included positive experiences with
CAM as well as positive assumptions regarding CAM
modalities that have not been tried by the participants
themselves. Furthermore, we looked at the types of
medications the participants used and the health care
professionals they visited for their health problems.
Additionally, we took care to account for the role of
chronic conditions as a possible confounder by run-
ning subgroup analyses for all comparisons. IHLOC
was assessed using a widely used and well-validated
instrument [9,10].
For non-significant mean differences, the trends also
pointed in the assumed directions. The lack of signifi-
cant differences in the subgroup of participants with a
chronic condition is likely due to the smaller sample size
(approximately 35% of the total sample).
Several limitations of this study must be discussed.
First, because of the cross-sectional study design, there
is no way to determine whether a higher IHLOC is a dis-
position that makes people prone to using CAM, or
whether it is a result of positive experiences with CAM
treatments. In a study by Hoffmann et al. [35] con-
cerning changes that occur during CAM treatment, an
increase in IHLOC was observed during inpatient inte-
grative medicine treatment of patients with chronic con-
ditions. However, the study lacked a control group. In
the interview study by Cartwright and Torr [36], the au-
thors describe how the participants adopt concepts from
CAM when they refer to “balance”, “qi”, “energy”, etc.
(p. 564), i.e., ideas and theories have been communicated
Table 3 IHLOC according to health-professionals’ consultation during the past six months
Total group Chronic condition No chronic condition
N Mean (SD) N Mean (SD) N Mean (SD)
CAM consultation only 24 32.58 (4.24) 8 34.00 (4.28) 16 31.88 (4.18)
Conventional consultation only 517 28.44 (4.96) 229 27.47 (5.36) 286 29.23 (4.49)
Both 78 29.08 (4.80) 42 28.83 (5.06) 35 29.49 (4.53)
No consultation 401 30.37 (4.67) 78 29.96 (5.39) 314 30.57 (4.48)
Total 1020 29.34 (4.93) 357* 28.32 (5.46) 651* 29.96 (4.53)
F (df) 15.78 (3,1016) 7.62 (3,353) 5.62 (3,647)
p <.001 <.001 <.01
Effect size f .22 .25 .16
*Sizes of subgroups do not add up to 1020 because of missing data regarding the presence/absence of a chronic condition.
Table 4 Subgroup comparisons regarding health professionals consultations
Total group Chronic condition No chronic condition
Difference
in IHLOC
t (df) p Difference
in IHLOC
t (df) p Difference
in IHLOC
t (df) p
No consultation vs. any consultation 1.00 .74 (1016) .46 −.42 −.15 (353) .88 1.13 .72 (647) .47
CAM consultation only vs. CAM and
conventional or conventional consulations only
7.65 3.73 (1016) <.001 11.70 3.03 (353) <.01 5.04 2.12 (647) <.05
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between them and their practitioner. Such results point
out the possible change of beliefs and expectations
during the course of treatment. However, it is generally
assumed that people chose CAM because it is in accord-
ance with beliefs that they already hold [7,37]. It would
be worthwhile to investigate IHLOC and CAM in a lon-
gitudinal design, i.e., assessing participants’ IHLOC be-
fore and after a CAM treatment. In that way, one could
detect changes in IHLOC as well as possible differences
between different CAM treatments (for example, yoga‘s
very active patient role, and homeopathy’s more passive
patient role).
Second, health statuses and chronic conditions were
only assessed through self-reports. Analyzing samples
with a confirmed diagnosis might be worthwhile to
come to a final conclusion regarding whether health
status is a confounder or not. Additionally, the CAM-
related variables might not be optimal, as discussed
elsewhere [25].
Third, although the sample was more heterogeneous
than student samples generally are, whether the results
can be generalized to the general population remains up
for debate. Also, results may be different in countries
with different reimbursement strategies of CAM treat-
ments since the status of CAM might be different in
such countries.
Methodologically, using the same sample that was
used in the BEE scale validation study makes this study
somewhat exploratory. Additionally, in the ANOVAs
and contrast analyses, the sample sizes of the com-
pared groups were quite different for some groups, es-
pecially for those of participants using only CAM
medications or practitioners, which included very few
participants. This is a serious problem and should be
addressed in further studies by recruiting part of the
sample in different settings, e.g., outpatient CAM
departments or practices. In addition to that, an alpha
of 0.05 was assumed in all statistical tests, resulting in
multiple testing. The results should therefore be inter-
preted with caution regarding statistical significance,
the more as only small to moderate effects could be
found. Additionally, the proportion of explained vari-
ance in IHLOC when using CAM appraisal, medica-
tion and consultation profiles as well as other possibly
confounding variables, such as chronic conditions, was
very low. This is in accordance with the rather small
effects found in the t-tests and ANOVAs.
In discussing the results, an important question has re-
cently been posed by Lindeman [38]: are there predictors
of CAM use that underlie the factors and beliefs com-
monly assumed to be related to CAM use? Her study used
a regression model with factors that have been investi-
gated with regard to CAM use in numerous studies, e.g.,
desire for control, health, education, gender, certain world
views, etc. In addition to that, intuitive thinking, core
knowledge confusions, and paranormal beliefs were added
as predictors. Those three predictors explained 34% of the
variance in CAM beliefs while all other predictors added
no more than 4% of the explained variance.
Therefore, the question is justified as to whether fo-
cusing on constructs such as locus of control is worth
further pursuit or if more general, underlying constructs
should be increasingly taken into account.
While that question remains debatable, our results in-
dicate that there are, in fact, differences in IHLOC when
comparing different groups of CAM users.
Conclusion
We found that IHLOC was related to CAM use by
looking at several indicators for CAM use. It remains
unclear whether people use CAM because it is in ac-
cordance with their higher IHLOC or if their IHLOC
Table 5 Results of the linear regression model predicting internal health locus of control (IHLOC)
Predictor B (95% CI) Beta P
Appraisal score .32 (.18, .45) .15 <.001
Chronic condition −1.18 (−1.84, −.52) -.11 <.001
Sex: female -.18 (−.96, .60) -.01 .65
Medication [Reference: only conventional medication]
Only CAM .36 (−.77, 1.49) .02 .53
Both CAM and conventional -.01 (−.78, .75) -.00 .97
None -.07 (−.91, .77) -.01 .86
Consultations [Reference: only conventional practitioners]
Only CAM 3.49 (1.50, 5.48) .11 <.01
Both CAM and conventional .40 (−.78, 1.59) .02 .50
None 1.73 (1.02, 2.43) .17 <.001
Age .01 (−.02, .05) .02 .44
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changes during CAM treatments. This question will
have to be evaluated using longitudinal studies or
structural equation modeling. Additionally, the role of
possible confounders should be further illuminated.
Abbreviation
CAM: Complementary and alternative medicine; BEE: Body-efficacy
expectation; IHLOC: Internal health locus of control; TCM: Traditional Chinese
Medicine.
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